Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in 5 Elderly Patients

Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in 5 Elderly Patients

Peripheral T cell lymphoma (PTCL) is a heterogeneous group of aggressive lymphomas with poor prognosis. Elderly (age ≥ 65years) patients generally have impaired bone marrow function, altered drug metabolism, comorbidities, and poor functional status. Thus, treatment of elderly patients with relapsed...

Full description

Bibliographic Details
Main Authors: Lee, Seung-Shin, Jung, Sung-Hoon, Ahn, Jae-Sook, Kim, Yeo-Kyeoung, Cho, Min-Seok, Jung, Seung-Yeon, Lee, Je-Jung, Kim, Hyeoung-Joon, Yang, Deok-Hwan
Format: Online
Language:English
Published: The Korean Academy of Medical Sciences 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901011/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901011/

Similar Items